The HYDROXYZINE PAMOATE CAPSULES is a the manufacturer industrial component. Key specifications include administration: INTRAMUSCULAR, special_features: 50 MG HYDROXYZINE HYDROCHLORIDE EQUIVALENT, features_provided: INDIVIDUALLY SEALED, primary_container_type: BOTTLE, therapeutic_equivalent: ANY A RATED DRUG, pharmaceutical_vehicle_type: AQUEOUS. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-00-765-0826, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAMUSCULAR |
| special_features | 50 MG HYDROXYZINE HYDROCHLORIDE EQUIVALENT |
| features_provided | INDIVIDUALLY SEALED |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | ANY A RATED DRUG |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 2.000 MILLILITERS |
| active_medicament_medicinal_strength | 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE PER MILLILITER |
| part_name_assigned_by_controlling_agency | HYDROXYZINE PAMOATE CAPSULES USP 50MG 100S BT |
| capsule_primary_container_content_quantity | 100.000 |
| NSN | 6505-00-765-0826 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 500.000 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT |
| PRIMARY CONTAINER TYPE | BOTTLE |